Eberhard, A; Moser, T; Hammer, S; Lang, K; Faschauner, P; Vlachos, G; Belic, J; Lazzeri, I; Pichler, M; Speicher, M; Bauernhofer, T; Heitzer, E
Paired analysis of blood plasma and urine reveals complementary information
in prostate cancer
DocDay; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Oral Communication]
Georgios Vlachos, Sabrina Weber, Tina Moser, Kevin Lang, Paul Faschauner, Anna Eberhard, Jelena Belic, Isaac Lazzeri, Martin Pichler, Michael Speicher, Thomas Bauernhofer, Ellen Heitzer
Paired analysis of blood plasma and urine reveals complementary information in prostate cancer
Advances in circulating tumor cells ; SEP 22-25, 2021; Kalamata, GREECE. 2021.
[Poster]
FullText
Moser, T; Waldispuehl-Geigl, J; Belic, J; Perakis, S; Weber, S; Zhou, Q; Sill, H; Lax, S; Kashofer, K; Hoefler, G; Schoellnast, H; Bauernhofer, T; Heitzer, E; Geigl, JB; Speicher, MR
Early circulating tumor DNA dynamics as a real-time predictor of FOLFOX efficacy in advanced colorectal cancer patients
CANCER RES. 2020; 80(16):
Doi: 10.1158/1538-7445.AM2020-4295
[Poster]
Web of Science
FullText
FullText_MUG
Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, C; St. John, J; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher,M
Inference of tumor cell-specific transcription factor binding from cell-free DNA enables tumor subtype prediction
Circulating Nucleic Acids in Plasma and Serum (CNAPS); SEP 23-25, 2019; Jerusalem, Israel. 2019.
[Poster]
FullText
Belic, J; Graf, R; Bauernhofer, T; Cherkas, Y; Peter, U; Waldispuehl-Geigl, J; Perakis, S; Gormley, M; Patel, J; Li, WM; Geigl, JB; Smirnov, D; Heitzer, E; Gross, M; Speicher, MR
Analysis of circulating tumor DNA reveals genomic alterations in metastatic prostate cancer patients treated with abiraterone acetate plus prednisone or enzalutamide
CANCER RES. 2018; 78(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 14-18, 2018; Chicago, IL.
Doi: 10.1158/1538-7445.AM2018-2959
[Oral Communication]
Web of Science
FullText
FullText_MUG
Jelena Belic, Peter Ulz, Ellen Heitzer, Maria Smolle, Thomas Bauernhofer, Katja Fischereder, Jochen B. Geigl1, Michael R. Speicher
Detection and characterization of neuroendocrine prostate cancer using whole genome-sequencing in circulating tumor DNA
3rd EACR Conference on Cancer Genomics; Jun 25-28, 2017; Cambridge, UK. 2017.
[Oral Communication]
FullText
Belic, J; Heitzer, E; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR
Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients
CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT.
Doi: 10.1158/1557-3265.PMSCLINGEN15-PR05
[Oral Communication]
Web of Science
FullText
FullText_MUG
Belic,J;Ulz,P; Graf, R; Auer, M; Fischereder, K; Hoefler, G;
Bauernhofer, T, Geigl, JB; Heitzer, E; Speicher, MR
Whole-genome sequencing of circulating tumor DNA reveals
relevance of focal amplifications for the management of
metastatic prostate cancer
Proceedings Book of the 24EACR. 2016; -EACR; JUL 9-12, 2016; Manchester, UK.
[Poster]
FullText
Jelena Belic, Peter Ulz, Ellen Heitzer, Martina Auer, Katja Fischereder, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher
Detection of clonal shifts in metastatic prostate cancer patients using whole genome-sequencing in circulating tumor DNA
10th ISMRC International Symposium on Minimal Residual Cancer:
Liquid Biopsy in Cancer Diagnostics and Treatment
; März 19-21, 2016; Hamburg, GERMANY. 2016.
[Oral Communication]
Smolle, MA; Pichler, M; Roßmann, C; Samonigg, H; Heitzer, E; Belic, J; Speicher, M; Pummer, K; Bauernhofer, T
Neuroendocrine transdifferentiation in castration resistant metastatic prostate cancer (mCRPC) - A case series
OeGHO & AHOP Frühjahrstagung; MAR 17 - 19, 2016; Vienna, AUSTRIA. 2016.
[Poster]
Ulz, P; Belic, J; Graf, R; Auer, M; Lafer, I; Fischereder, K; Webersinke, G; Pummer, K; Augustin, H; Pichler, M; Hoefler, G; Bauernhofer, T; Geigl, JB; Heitzer, E; Speicher, MR;
Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
16. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 30, 2016; Vienna, AUSTRIA. 2016.
[Oral Communication]
Ulz, P; Heitzer, E; Auer, M; Belic, J; Perakis, S; Geigl, JB; Speicher, MR;
Krebsdiagnostik aus dem peripheren Blut: Zirkulierende Tumor DNA (ctDNA)
Forum Spital 2016, Update Onkologie; JUN 15-16, 2016; Vösendorf, AUSTRIA. 2016.
[Oral Communication]
Belic, J; Heitzer, E; Ulz, P ; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR
Analysis of ctDNA using mFastSeqS and plasma–Seq methods for screening and therapy monitoring in prostate cancer patients
AACR Precision Medicine Series: Integrating Clinical Genomics and Cancer Therapy; June 13-16, 2015; Salt Lake City, Utah, USA. 2015.
[Oral Communication]
FullText
Belic, J; Koch, M; Ulz, P; Auer, M; Fischereder, K; Bauernhofer, T; Geigl, JB; Speicher, MR Heitzer, E
Modified FAST-SeqS approach as a pre-screening method for detection of plasma samples with elevated ctDNA in prostate cancer patients
EACR CONFERENCE SERIES 2015
2ND SPECIAL CONFERENCE: CANCER GENOMICS; 28 JUNE – 1 JULY 2015; Cambridge, UK. 2015.
[Poster]
FullText
Heitzer, E; Ulz, P; Auer, M; Belic, J; Sumitra, M; Lax, S; Hoefler, G; Augustin, H; Edgar, P; Bauernhofer, T; Geigl, J; Speicher, M
Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs
EUR J CANCER. 2015; 51: S33-S33.-European Cancer Congress; Sep 25-29, 2015; Vienna, AUSTRIA.
Doi: 10.1016/S0959-8049(16)30108-3
[Poster]
Web of Science
FullText
FullText_MUG
J. Belic, M. Koch, P. Ulz, M. Auer, K. Fischereder, T. Bauernhofer, J. B. Geigl, M. R. Speicher, E. Heitzer
Modified FAST-SeqS approach as a pre-screening method for detection of plasma samples with elevated ctDNA in prostate cancer patients
2nd EACR Special Conference on Cancer Genomics, Churchill College; June-July 28-1, 2015; Cambridge, UK. 2015.
[Poster]
Ulz, P; Auer, M; Belic, J; Lafer I; Jahn, SW; Pristauz, G; Heidary, M; Schwarzbraun, T; Fischereder K; Gerger, A; Hoefler; G; Augustin, H; Bauernhofer, T; Petru, E; Heitzer, E; Geigl, JB; Speicher, MR
Circulating tumor DNA sequencing reveals cancer driver genes and their plasticity
in focal amplifications
Medizinische Genetik. 2015; 27(1):79-109.-26. Jahrestagung der Deutschen Gesellschaft für Humangenetik gemeinsam mit der Österreichischen Gesellschaft für Humangenetik und der Schweizerischen Gesellschaft für Medizinische Genetik; APR 15-17, 2015; Graz, AUSTRIA.
[Oral Communication]
FullText
Ulz, P; Heitzer, E; Belic, J; Auer, M; Geigl, JB, Speicher, MR;
Analysis of cell-free DNA in metastasized cancer patients using next-generation sequencing
5th Polish Illumina Symposium; OCT 15-16, 2015; Poznan, POLAND. 2015.
[Oral Communication]
Ulz, P; Heitzer, E; Belic, J; Lafer, I; Schwarzbraun, T; Bauernhofer, T; Eisner, F; Pichler, M; Fischereder, K; Gutschi, S; Augustin H; Pummer K; Webersinke, G; Geigl, JB; Speicher, MR;
Whole-genome plasma sequencing reveals focal amplifications as driving force in metastatic prostate cancer
15. Jahrestagung der Österreichischen Gesellschaft für Humangenetik; SEP 25, 2015; Salzburg, AUSTRIA. 2015.
[Oral Communication]
Zuckermann, M; Hovestadt, V; Knobbe-Thomsen, CB; Zapatka, M; Northcott, PA; Schramm, K; Belic, J; Jones, DTW; Tschida, B; Moriarity, B; Largaespada, D; Roussel, MF; Korshunov, A; Reifenberger, G; Pfister, SM; Lichter, P; Kawauchi, D; Gronych, J
Somatic CRISPR/Cas9-mediated tumor suppressor disruption enables versatile brain tumor modeling
CANCER RES. 2015; 75: -AACR Special Conference on Advances in Brain Cancer Research; MAY 27-30, 2015; Washington, DC.
Doi: 10.1158/1538-7445.BRAIN15-PR02
[Poster]
Web of Science
FullText
FullText_MUG
Belic, J; Ulz, P; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR
Analysis of plasma DNA using whole genome sequencing in patients with prostate cancer
Gordon Research Seminar & Conference; July, 7-12,2013; RI, USA. 2013.
[Oral Communication]
Belic, J; Ulz, P; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR
Whole genome plasma DNA sequencing as a non-invasive tool for personalized therapy in prostate cancer patients
EMBL Conference, Cancer Genomix; Nov 3-5, 2013; Heidelberg, Germany. 2013.
[Oral Communication]
Heitzer, E; Ulz, P; Belic, J; Gutschi, S; Quehenberger, F; Auer, M; Augustin, H; Hoefler, G; Geigl, JB; Speicher, MR
Tumor associated copy number changes identified by whole-genome sequencing in the circulation of patients with prostate cancer
EUR J CANCER. 2013; 49: S98-S98.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS.
[Oral Communication]
Web of Science
Belic, J; Auer, M; Heitzer, E; Gutschi, S; Fischereder, K; Pichler, M; Ulz, P; Geigl, J; Augustin, H; Eisner, F; Höfler, G; Pantel, K; Riethdorf, S; Geigl, JB; Speicher, MR
Characterization of circulating tumor cells and plasma DNA in patients with prostate cancer
Doctoral day; dec 7,2012; Graz, Austria. 2012.
[Poster]